Trial Details
COMPLETEDBasic Information
| Clinical ID | c434 |
|---|---|
| Identifier | NCT03606499 |
| Trial Title | Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory Diseases |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease|Colitis, Ulcerative |
| Interventions | DRUG: Ustekinumab |
Participant Information
| Sponsor | Janssen Cilag S.A.S. |
|---|---|
| City | Vandoeuvre les Nancy |
| Country/Region | France |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2018-09-26 |
|---|---|
| Primary Completion Date | 2023-03-17 |
| Completion Date | 2023-03-17 |